Kuijpers P M J C, Honig A, Wellens H J J
Department of Psychiatry, University Hospital, Maastricht, The Netherlands.
Gen Hosp Psychiatry. 2002 May-Jun;24(3):181-4. doi: 10.1016/s0163-8343(02)00176-7.
Anxiety and depression are common in patients receiving an implantable cardioverter defibrillator (ICD). An association between the number of ICD discharges and mood disturbances has been found. We performed a pilot study in ICD patients with frequent ICD shocks having a comorbid diagnosis of panic disorder with agoraphobia and depression, in which we treated them with a combination of a selective serotonin reuptake inhibitor (SSRI) and a behavior program. We hypothesized that this intervention would result in a decrease of ventricular premature beats or arrhythmias and possibly in a reduction of number of shocks. Four of 5 patients treated with such a combination therapy experienced no discharge of the ICD during a 6 month follow-up. The total number of ventricular premature beats decreased significantly after treatment. There was also clear psychiatric improvement. These results warrant larger scale studies on the pathophysiological mechanisms as well as treatment issues.
焦虑和抑郁在接受植入式心脏复律除颤器(ICD)的患者中很常见。已发现ICD放电次数与情绪障碍之间存在关联。我们对患有惊恐障碍伴广场恐惧症和抑郁症合并症且频繁发生ICD电击的ICD患者进行了一项试点研究,在该研究中我们用选择性5-羟色胺再摄取抑制剂(SSRI)和行为程序相结合的方法对他们进行治疗。我们假设这种干预将导致室性早搏或心律失常减少,并可能减少电击次数。接受这种联合治疗的5名患者中有4名在6个月的随访期间未发生ICD放电。治疗后室性早搏总数显著减少。精神状态也有明显改善。这些结果值得对病理生理机制以及治疗问题进行更大规模的研究。